Radiopharmaceutical provider DraxImage has signed a manufacturing contract to supply sodium iodide I-131 radiotherapy capsules to Bracco Diagnostics of Princeton, NJ for U.S. distribution. Shipments of the capsules -- used to treat thyroid cancer and hyperthyroidism -- are expected to begin by the end of the third quarter, according to Mississauga, Ontario-based DraxImage.
By AuntMinnie.com staff writersAugust 23, 2001
Related Reading
Draxis posts higher revenues in Q2, August 13, 2001
DraxImage gets clearance for palladium version of BrachySeed, June 28, 2001
DraxImage gets new president, June 20, 2001
DraxImage files for approval for brachytherapy implant, April 27, 2001
DraxImage licenses Infecton Agent, March 15, 2001
Copyright © 2001 AuntMinnie.com
